UNITED THERAPEUTICS Corp Logo

UNITED THERAPEUTICS Corp

Develops therapies for chronic diseases and manufactures organs for transplantation.

UTHR | US

Overview

Corporate Details

ISIN(s):
US91307C1027
LEI:
Country:
United States of America
Address:
1000 SPRING ST, 20910 SILVER SPRING
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

United Therapeutics Corporation is a biotechnology company structured as a public benefit corporation (PBC). It focuses on the research, development, and commercialization of unique products and innovative therapies for patients with chronic and life-threatening conditions. The company's primary therapeutic areas include treatments for cardiovascular diseases, such as pulmonary arterial hypertension. United Therapeutics is also a leader in developing technologies to address the shortage of transplantable organs, including organ manufacturing and xenotransplantation, with the goal of providing a brighter future for patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all UNITED THERAPEUTICS Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for UNITED THERAPEUTICS Corp

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for UNITED THERAPEUTICS Corp via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Co-Diagnostics, Inc. Logo
Develops patented PCR solutions for accurate infectious disease diagnostics.
United States of America
CODX
co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany
CNW
Coeptis Therapeutics Holdings, Inc. Logo
Develops cell therapy platforms for cancer, autoimmune, and infectious diseases.
United States of America
COEP
COGNITION THERAPEUTICS INC Logo
Clinical-stage biopharma developing small-molecule drugs for Alzheimer's and dementia.
United States of America
CGTX
Coherus Oncology, Inc. Logo
Commercial-stage biopharma developing immuno-oncology therapies for hard-to-treat cancers.
United States of America
CHRS
COLLEGIUM PHARMACEUTICAL, INC Logo
Develops and commercializes abuse-deterrent medications for responsible chronic pain management.
United States of America
COLL
CollPlant Biotechnologies Ltd Logo
Develops rhCollagen for 3D bioprinting of tissues for regenerative & aesthetic medicine.
United States of America
CLGN
Compass Therapeutics, Inc. Logo
A clinical-stage oncology firm developing antibody therapies that engage the immune system.
United States of America
CMPX
Compugen Ltd. Logo
Uses AI to discover and develop novel antibody immunotherapies for hard-to-treat cancers.
Israel
CGEN
COMPUGEN LTD Logo
AI-driven discovery of novel cancer immunotherapies for treatment-resistant patients.
United States of America
CGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.